Paul Song

Company: NKGen Biotech

Job title: Chief Executive Officer

Seminars:

Evaluating Adoptive Cellular Immunotherapy for Neurodegeneration with Autologous SNK01 2:30 pm

Enhancing natural killer cells to maximize the body’s ability to destroy diseased and abnormal cells Reviewing NK cell therapy as an alternative modality of treatment to resolve neurodegeneration with the body’s natural immune system Exploring phase 1 clinical safety and efficacy data of autologous SNK01 in treating neurodegenerative diseaseRead more

day: Translational Track Day 2 PM